Summit Global Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.17M | Sell |
14,575
-2,341
| -14% | -$519K | 0.19% | 56 |
|
|
2025
Q4 | $3.87M | Buy |
16,916
+2,987
| +21% | +$680K | 0.23% | 53 |
|
|
2025
Q3 | $3.23M | Sell |
13,929
-285
| -2% | -$58K | 0.19% | 77 |
|
|
2025
Q2 | $2.64M | Buy |
14,214
+10,935
| +333% | +$2.03M | 0.16% | 94 |
|
|
2025
Q1 | $687K | Sell |
3,279
-9,986
| -75% | -$1.94M | 0.05% | 244 |
|
|
2024
Q4 | $2.36M | Buy |
13,265
+1,619
| +14% | +$298K | 0.15% | 118 |
|
|
2024
Q3 | $2.3M | Sell |
11,646
-1,232
| -10% | -$230K | 0.15% | 120 |
|
|
2024
Q2 | $2.21M | Sell |
12,878
-2,243
| -15% | -$372K | 0.15% | 124 |
|
|
2024
Q1 | $2.75M | Sell |
15,121
-42,935
| -74% | -$7.4M | 0.2% | 93 |
|
|
2023
Q4 | $9M | Sell |
58,056
-6,530
| -10% | -$952K | 0.59% | 35 |
|
|
2023
Q3 | $9.63M | Buy |
64,586
+1,389
| +2% | +$204K | 0.64% | 37 |
|
|
2023
Q2 | $8.52M | Buy |
63,197
+45,677
| +261% | +$6.7M | 0.56% | 41 |
|
|
2023
Q1 | $2.79M | Sell |
17,520
-40,240
| -70% | -$6.15M | 0.22% | 111 |
|
|
2022
Q4 | $9.34M | Sell |
57,760
-1,082
| -2% | -$166K | 0.79% | 28 |
|
|
2022
Q3 | $7.9M | Buy |
58,842
+259
| +0.4% | +$37.2K | 0.73% | 33 |
|
|
2022
Q2 | $8.97M | Sell |
58,583
-64,222
| -52% | -$9.81M | 0.79% | 34 |
|
|
2022
Q1 | $19.9M | Buy |
122,805
+79,584
| +184% | +$11.6M | 1.47% | 12 |
|
|
2021
Q4 | $5.85M | Buy |
43,221
+6,110
| +16% | +$722K | 0.38% | 64 |
|
|
2021
Q3 | $4M | Sell |
37,111
-2,443
| -6% | -$279K | 0.3% | 75 |
|
|
2021
Q2 | $4.45M | Sell |
39,554
-967
| -2% | -$109K | 0.27% | 77 |
|
|
2021
Q1 | $4.38M | Buy |
40,521
+486
| +1% | +$52K | 0.28% | 68 |
|
|
2020
Q4 | $4.29M | Buy |
40,035
+6,410
| +19% | +$616K | 0.43% | 57 |
|
|
2020
Q3 | $2.94M | Sell |
33,625
-1,397
| -4% | -$132K | 0.3% | 60 |
|
|
2020
Q2 | $3.44M | Buy |
35,022
+15,468
| +79% | +$1.36M | 0.4% | 47 |
|
|
2020
Q1 | $1.49M | Sell |
19,554
-84,898
| -81% | -$7.23M | 0.22% | 62 |
|
|
2019
Q4 | $9.25M | Buy |
104,452
+1,148
| +1% | +$95.3K | 1% | 36 |
|
|
2019
Q3 | $7.82M | Sell |
103,304
-119,855
| -54% | -$8.22M | 0.91% | 41 |
|
|
2019
Q2 | $16.2M | Buy |
223,159
+103,471
| +86% | +$8.13M | 2.04% | 7 |
|
|
2019
Q1 | $9.65M | Buy |
+119,688
| New | +$9.79M | 1.23% | 25 |
|
|
2018
Q4 | – | Sell |
-2,327
| Closed | -$220K | – | 251 |
|
|
2018
Q3 | $220K | Sell |
2,327
-200
| -8% | -$19K | 0.03% | 244 |
|
|
2018
Q2 | $234K | Sell |
2,527
-49,787
| -95% | -$4.86M | 0.04% | 244 |
|
|
2018
Q1 | $4.95M | Buy |
52,314
+14,689
| +39% | +$1.61M | 0.79% | 41 |
|
|
2017
Q4 | $3.64M | Buy |
+37,625
| New | +$3.55M | 0.56% | 48 |
|
Other funds holding ABBV
VCM
VPM
Summit Global Investments's ABBV Position: Q1 2026 in Review
Summit Global Investments reduced its AbbVie (ABBV) stake by 14% in Q1 2026, selling an estimated $519K and leaving 14,575 shares worth $3.17M. The position accounts for 0.19% of the portfolio, ranked #56.
Summit Global Investments first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. The position peaked at $19.9M in Q1 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Summit Global Investments held 14,575 shares of AbbVie worth $3.17M as of Q1 2026.
- Summit Global Investments sold 2,341 AbbVie shares in Q1 2026, an estimated $519K.
- AbbVie made up 0.19% of Summit Global Investments's portfolio in Q1 2026, its #56 holding.
- Summit Global Investments first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
- Summit Global Investments's AbbVie position peaked at $19.9M in Q1 2022.
- 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.